Informations générales (source: ClinicalTrials.gov)
Impact of Stress Management Training on Quality of Life and Cardiac Post-transplantation Complications in a Controlled Multicentric Comparative Study. (QUIET)
Interventional
Phase 3
Hospices Civils de Lyon (Voir sur ClinicalTrials)
avril 2015
décembre 2020
29 juin 2024
In spite of major medical advances in heart transplant patients, psychiatric comorbidity
remains very high in pre-and post-transplant phases. Anxiety and depression are
especially frequent. They impact significantly morbidity and mortality. Especially
because they are associated with poor therapeutic adherence and risks of infection and
rejection. The inability to make beneficial therapeutic choice can be explained by the
negative perception of events, associated with anxio-depressive disorders. This results
in an important deterioration in quality of life of patients.
The investigators assume that better management of emotions might reduce the stress of
waiting situation and its psychopathological and somatic consequences pre-and
post-transplant.
Etablissements
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| Pôle de Psychiatrie et de Neurologie - Grenoble - France | Thierry BOUGEROL, MD | Contact (sur clinicalTrials) | |||
| Service de Psychiatrie d'Adultes Liaison/Consultation, - 69677 - Bron - France | Mohamed SAOUD, PR | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- Men and women on the cardiac transplantation waiting list
- Patients aged 18 years and older
- Signed written informed consent
- Patients under the social security
- Patients with a somatic condition allowing travels
- Patients mastering the French language
- Class II or III NYHA patients
- Men and women on the cardiac transplantation waiting list
- Patients aged 18 years and older
- Signed written informed consent
- Patients under the social security
- Patients with a somatic condition allowing travels
- Patients mastering the French language
- Class II or III NYHA patients
- Patients minor or under protection measures
- Patient who have not signed written informed consent
- Patients not mastering the French language
- Patients with psychiatric illness characterized by the axis 1 of DSM IV R
- Patients receiving a psychotherapy or with a psychiatric care
- class IV NYHA patients